tuberculosis

See the following -

Promising Antibiotic Discovered In Microbial "Dark Matter"

Heidi Ledford | Scientific American | January 7, 2015

Potential drug kills pathogens such as MRSA—and was discovered by mining "unculturable" bacteria...

Read More »

Revolutionary New Antibiotic Alternative Could Save The World From Superbug 'Apocalypse'

Amelia Smith | Newsweek | November 6, 2014

Scientists have developed a new alternative to antibiotics that could revolutionise the way we treat superbugs and avoid a scenario where common medical procedures become life-threatening due to bacteria becoming immune to conventional drugs...

Read More »

Scientists Develop ‘Lab on a Chip’ That Costs 1 Cent to Make

Press Release | Stanford University School of Medicine | February 6, 2017

Researchers at the Stanford University School of Medicine have developed a way to produce a cheap and reusable diagnostic “lab on a chip” with the help of an ordinary inkjet printer. At a production cost of as little as 1 cent per chip, the new technology could usher in a medical diagnostics revolution like the kind brought on by low-cost genome sequencing, said Ron Davis, PhD, professor of biochemistry and of genetics and director of the Stanford Genome Technology Center...

South Africa’s Quadruple Burden of Disease

Three years ago, I found myself on a bus in South Africa, with fifteen of my college classmates. We were on our way to Kruger National Park, after a week of volunteering and researching in Cape Town. As I stared out the window, appreciating rural South Africa’s beauty, a large billboard, seemingly in the middle of nowhere, caught my attention. “Relay for Life: A Fundraiser for the American Cancer Society.” This poster piqued my curiosity. I had always associated South Africa with HIV/AIDS and tuberculosis. In fact, I had documented a handful of posters in Cape Town that aimed to combat HIV/AIDS by reducing stigma and encouraging testing...

Read More »

Superbugs Will Kill 10 Million a Year by 2050

Zack Budryk | Fierce Healthcare | May 19, 2016

Healthcare experts have long warned drug-resistant superbugs are a "looming global threat," but left unchecked, they may kill someone every three seconds by 2050, according to a new report. The Review on Antimicrobial Resistance began in 2014 and in the meantime, antibiotic-resistant infections have already wrought havoc, causing several outbreaks linked to contaminated scopes and proving potentially more deadly than cancer, according to experts...

Read More »

The Collateral Benefits of India's Open Source Drug Discovery Programme

Priyanka Pulla | Forbes India | April 9, 2014

India's Open Source Drug Discovery programme is struggling for lack of expertise and a research ecosystem. However, the programme's real contribution may be the creation of just such an ecosystem Read More »

The Grim Propect of Antibiotic Resistance

Staff Writer | The Economist | May 21, 2016

When people hear about antibiotic resistance creating “superbugs”, they tend to think of new diseases and pandemics spreading out of control. The real threat is less flamboyant, but still serious: existing problems getting worse, sometimes dramatically. Infections acquired in hospital are a prime example. They are already a problem, but with more antibiotic resistance they could become a much worse one. Elective surgery, such as hip replacements, now routine, would come to carry what might be seen as unacceptable risk. So might Caesarean sections. The risks of procedures which suppress the immune system, such as organ transplants and cancer chemotherapies, would increase...

Read More »

The Underreported Side Of The Ebola Crisis

Rose Ann DeMoro | The Blog | September 6, 2014

Amid the media accounts of the worst Ebola outbreak ever recorded some significant context is largely missing from the major media reporting.  Atop this list are links of the outbreak to the climate crisis and global inequality, mal-distribution of wealth, and austerity-driven cuts in public services that have greatly contributed to the rapid spread of Ebola...

Read More »

Waste from Pharmaceutical Plants in India and China Promotes Antibiotic-Resistant Superbugs

Henry A. Waxman and Bill Corr | STAT | October 14, 2016

Superbugs, disease-causing microbes that have mutated to become resistant to antibiotics, are a threat to the lives of hundreds of thousands of people today and many millions tomorrow. These organisms turn curable illnesses such as tuberculosis, gonorrhea, and pneumococcal pneumonia into deadly ones. This looming public health disaster has many causes. Overuse of antibiotics by humans and the routine use of antibiotics to help farm animals grow faster are key causes in the United States. One worrisome cause that has received virtually no attention until now is wastewater from drug manufacturing facilities in India and China, where a large portion of the world’s antibiotic supply is produced...

Read More »

‘Superbug’ Scourge Spreads as U.S. Fails to Track Rising Human Toll

Ryan McNeill, Deborah J. Nelson and Yasmeen Abutaleb | Reuters | September 7, 2016

Fifteen years after the U.S. declared drug-resistant infections to be a grave threat, the crisis is only worsening, a Reuters investigation finds, as government agencies remain unwilling or unable to impose reporting requirements on a healthcare industry that often hides the problem...

Read More »